EUVIMEDAtrasti EUVIMED
FallberichtÜbersichtsarbeitOpen access · CC BY-NC-ND 4.0

Therapeutic Plasma Exchange for the Symptomatic Treatment of Scleromyxedema: A Case Report and Literature Review

Matthew H Lanehart, Erika S Johnson, Nicole A Aqui

Journal of Clinical Apheresis · 2024

DOI: 10.1002/jca.22153 ↗

At a glance

Fallbericht in Journal of Clinical Apheresis, 2024. Written by Matthew H Lanehart and 2 co-authors. Institution: Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA. Major MEDLINE topics: Scleromyxedema, Plasma Exchange. Cited 4 times so far (Crossref); 19 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

SantraukaSubjectsBibliografiniai duomenysCiteRelated studies

Abstract (original language)

Scleromyxedema is a rare skin mucinosis often associated with systemic involvement and monoclonal gammopathy (MG). No formal recommendation for management with therapeutic plasma exchange (TPE) has been published due to rarity. This paper reports a 42‐year‐old male with progressive scleromyxedema. The patient was treated with glucocorticoids, immunosuppressants, and intravenous immunoglobulin (IVIG) therapy, but the disease progressed. Ultimately, the patient was referred for TPE, which resulted in decreased skin stiffness, improved extremity range of motion, and decreased visibility of papules on the hands. The patient's debilitating dysphagia gradually improved. A review of the literature focusing on clinical response identified five cases of scleromyxedema patients treated with TPE. Three of the five cases reported significant improvement in cutaneous symptoms and range of motion for at least 12 months. Overall, we propose that TPE should be considered an effective supportive treatment for symptomatic relief in severe or refractory scleromyxedema.

Subjects

MeSH terms (MEDLINE)

ScleromyxedemaPlasma ExchangeHumansAdultMaleImmunoglobulins, IntravenousTreatment OutcomeImmunosuppressive Agents

Author keywords

TPEmonoclonal gammopathymyopathypapular mucinosisscleromyxedema

Substances

Immunoglobulins, IntravenousImmunosuppressive Agents

Authors and institutions

  • Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • West Virginia University School of Medicine, Morgantown, West Virginia, USA.

Cite

APA

Lanehart, M. H., Johnson, E. S., & Aqui, N. A. (2024). Therapeutic Plasma Exchange for the Symptomatic Treatment of Scleromyxedema: A Case Report and Literature Review. Journal of Clinical Apheresis. https://doi.org/10.1002/jca.22153

Vancouver

Lanehart MH, Johnson ES, Aqui NA. Therapeutic Plasma Exchange for the Symptomatic Treatment of Scleromyxedema: A Case Report and Literature Review. Journal of Clinical Apheresis. 2024. doi:10.1002/jca.22153

BibTeX
@article{Lanehart2024,
  author = {Lanehart, Matthew H and Johnson, Erika S and Aqui, Nicole A},
  title = {Therapeutic Plasma Exchange for the Symptomatic Treatment of Scleromyxedema: A Case Report and Literature Review},
  journal = {Journal of Clinical Apheresis},
  year = {2024},
  doi = {10.1002/jca.22153}
}
Start for free →